Cargando…

Exploring the OncoGenomic Landscape of cancer

BACKGROUND: The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients. A main current challenge is to find out reliable ways to extrapolate results from one group of patients to another and to br...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateo, Lidia, Guitart-Pla, Oriol, Duran-Frigola, Miquel, Aloy, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090738/
https://www.ncbi.nlm.nih.gov/pubmed/30071882
http://dx.doi.org/10.1186/s13073-018-0571-0
_version_ 1783347247779414016
author Mateo, Lidia
Guitart-Pla, Oriol
Duran-Frigola, Miquel
Aloy, Patrick
author_facet Mateo, Lidia
Guitart-Pla, Oriol
Duran-Frigola, Miquel
Aloy, Patrick
author_sort Mateo, Lidia
collection PubMed
description BACKGROUND: The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients. A main current challenge is to find out reliable ways to extrapolate results from one group of patients to another and to bring rationale to individual cases in the light of what is known from the cohorts. RESULTS: We present OncoGenomic Landscapes, a framework to analyze and display thousands of cancer genomic profiles in a 2D space. Our tool allows users to rapidly assess the heterogeneity of large cohorts, enabling the comparison to other groups of patients, and using driver genes as landmarks to aid in the interpretation of the landscapes. In our web-server, we also offer the possibility of mapping new samples and cohorts onto 22 predefined landscapes related to cancer cell line panels, organoids, patient-derived xenografts, and clinical tumor samples. CONCLUSIONS: Contextualizing individual subjects in a more general landscape of human cancer is a valuable aid for basic researchers and clinical oncologists trying to identify treatment opportunities, maybe yet unapproved, for patients that ran out of standard therapeutic options. The web-server can be accessed at https://oglandscapes.irbbarcelona.org/. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13073-018-0571-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6090738
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60907382018-08-17 Exploring the OncoGenomic Landscape of cancer Mateo, Lidia Guitart-Pla, Oriol Duran-Frigola, Miquel Aloy, Patrick Genome Med Software BACKGROUND: The widespread incorporation of next-generation sequencing into clinical oncology has yielded an unprecedented amount of molecular data from thousands of patients. A main current challenge is to find out reliable ways to extrapolate results from one group of patients to another and to bring rationale to individual cases in the light of what is known from the cohorts. RESULTS: We present OncoGenomic Landscapes, a framework to analyze and display thousands of cancer genomic profiles in a 2D space. Our tool allows users to rapidly assess the heterogeneity of large cohorts, enabling the comparison to other groups of patients, and using driver genes as landmarks to aid in the interpretation of the landscapes. In our web-server, we also offer the possibility of mapping new samples and cohorts onto 22 predefined landscapes related to cancer cell line panels, organoids, patient-derived xenografts, and clinical tumor samples. CONCLUSIONS: Contextualizing individual subjects in a more general landscape of human cancer is a valuable aid for basic researchers and clinical oncologists trying to identify treatment opportunities, maybe yet unapproved, for patients that ran out of standard therapeutic options. The web-server can be accessed at https://oglandscapes.irbbarcelona.org/. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13073-018-0571-0) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-03 /pmc/articles/PMC6090738/ /pubmed/30071882 http://dx.doi.org/10.1186/s13073-018-0571-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Software
Mateo, Lidia
Guitart-Pla, Oriol
Duran-Frigola, Miquel
Aloy, Patrick
Exploring the OncoGenomic Landscape of cancer
title Exploring the OncoGenomic Landscape of cancer
title_full Exploring the OncoGenomic Landscape of cancer
title_fullStr Exploring the OncoGenomic Landscape of cancer
title_full_unstemmed Exploring the OncoGenomic Landscape of cancer
title_short Exploring the OncoGenomic Landscape of cancer
title_sort exploring the oncogenomic landscape of cancer
topic Software
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090738/
https://www.ncbi.nlm.nih.gov/pubmed/30071882
http://dx.doi.org/10.1186/s13073-018-0571-0
work_keys_str_mv AT mateolidia exploringtheoncogenomiclandscapeofcancer
AT guitartplaoriol exploringtheoncogenomiclandscapeofcancer
AT duranfrigolamiquel exploringtheoncogenomiclandscapeofcancer
AT aloypatrick exploringtheoncogenomiclandscapeofcancer